Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Johnson

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Tree Physiology|July 5, 2011
Hydraulic patterns and safety margins, from stem to stomata, in three eastern U.S. tree speciesD M Johnson, K A McCulloh, F C Meinzer, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compoundsR N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study GroupC H Ballow, R N Jones, D M Johnson, et al.
Science (New York, N.Y.)|September 6, 1991
Targeted gene replacement in Drosophila via P element-induced gap repairG B Gloor, N A Nassif, D M Johnson-Schlitz, et al.
European Journal of Clinical Investigation|January 13, 2006
Non-haem iron transport in the rat proximal colonK L Johnston, D M Johnson, J Marks, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1996
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference testsD M Johnson, G V Doern, T A Haugen, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Tree Physiology|July 5, 2011
Hydraulic patterns and safety margins, from stem to stomata, in three eastern U.S. tree speciesD M Johnson, K A McCulloh, F C Meinzer, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compoundsR N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study GroupC H Ballow, R N Jones, D M Johnson, et al.
Science (New York, N.Y.)|September 6, 1991
Targeted gene replacement in Drosophila via P element-induced gap repairG B Gloor, N A Nassif, D M Johnson-Schlitz, et al.
European Journal of Clinical Investigation|January 13, 2006
Non-haem iron transport in the rat proximal colonK L Johnston, D M Johnson, J Marks, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1996
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference testsD M Johnson, G V Doern, T A Haugen, et al.
Pageof 12